Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT03785340
Previous Study | Return to List | Next Study

Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03785340
Recruitment Status : Completed
First Posted : December 24, 2018
Results First Posted : June 6, 2022
Last Update Posted : June 30, 2022
Sponsor:
Information provided by (Responsible Party):
Ocugen

Information on FDAAA 801 Violations
More Information: Notices of Noncompliance [FDA]
Table of FDAAA 801 Violation Notices
Available on ClinicalTrials.gov Issued by FDA Study Record Submitted Notice Type FDAAA 801 Notice
April 20, 2022 April 15, 2022 July 15, 2020 Violation Identified by FDA Failure to Submit. The entry for this clinical trial was not complete at the time of submission, as required by law. This may or may not have any bearing on the accuracy of the information in the entry.